Author Affiliations: National Health Service Research and Development Centre for Evidence-Based Medicine, John Radcliffe Hospital, Oxford, England (Drs McAlister and Sackett); Division of General Internal Medicine, Ottawa Hospital (Dr Laupacis), and Clinical Epidemiology Unit, Loeb Health Research Institute (Drs Laupacis and Wells), Ottawa, Ontario.
Users' Guides to the Medical Literature Section
Editor: Drummond Rennie, MD, Deputy Editor (West), JAMA.
Most classes of drugs include multiple compounds. The opinions of clinicians,
manufacturers, and purchasers may differ as to whether a particular drug is
more efficacious, safer, or more cost-effective than others in its class.1 In this article, we review the types of evidence commonly
cited to support the prescribing of a particular drug rather than another
of the same class and provide a hierarchy for grading studies that compare
a drug with another of the same class, expanding on our discussion in part
A of this Users' Guide.2
McAlister FA, Laupacis A, Wells GA, Sackett DL, for the Evidence-Based Medicine Working Group. Users' Guides to the Medical Literature: XIX. Applying Clinical Trial ResultsB. Guidelines for Determining Whether a Drug Is Exerting (More Than) a Class Effect. JAMA. 1999;282(14):1371–1377. doi:10.1001/jama.282.14.1371
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: